Associate Professor of Gastroenterology at Marmara University School of Medicine in Istanbul, Türkiye, and serves as an Adjunct Assistant Professor at Yale University School of Medicine. His clinical and research focus is in hepatology, with particular interest in portal hypertension and hepatocellular carcinoma, including non-invasive risk stratification, early detection, and outcomes research. He is actively involved in international collaborations and serves as the Communication Lead for the AASLD Portal Hypertension Special Interest Group.

I am a transplant hepatologist and gastroenterologist at the West Haven VA Medical Center and an Assistant Professor of Medicine at the Yale School of Medicine. My clinical and research interests include cirrhosis, portal hypertension, and the prevention and management of complications of advanced liver disease.

Dr. Heather Patton is a Transplant Hepatologist, Professor of Medicine at UC San Diego and the Section Chief of Gastroenterology for the VA San Diego Healthcare System. She currently serves on the Hepatology Field Advisory Board to the VHA National Gastroenterology and Hepatology Program Office and vice chair of the MASLD field advisory board.

Dr. Chen is currently an Assistant Professor in the Division of Gastroenterology and Hepatology at the University of Michigan Medical School. He completed his undergraduate studies at Amherst College, followed by medical school at Harvard Medical School, residency at Stanford University Medical Center, and gastroenterology and hepatology fellowships at the University of Michigan. During fellowship, he obtained a Master in Science in Bioinformatics at University of Michigan. Dr. Chen's primary research interests are in precision health and genetics in liver disease.

Mazen Noureddin, MD, MHSc, is a Professor of Medicine and an internationally recognized leader in Steatotic Liver Disease (SLD) and SLD-related cirrhosis. He completed his internal medicine residency at the University of Southern California (USC), followed by advanced hepatology training at the National Institutes of Health (NIH) within the NIDDK Liver Diseases Branch, where he also earned an NIH/Duke Master of Health Sciences in Clinical Research. He subsequently completed a gastroenterology fellowship at the University of California, San Diego (UCSD) as a T32 NIH fellow.

Dr. Scherer completed a combined Transplant Hepatology and Gastroenterology Fellowship at Indiana University School of Medicine in June 2026, after which he took a position as Assistant Professor of Clinical Medicine at Indiana University School of Medicine. In his work as a transplant hepatologist, his clinical and clinical research interests focus on improving patient outcomes after liver transplantation. He currently serves on the AASLD Training and Workforce Committee.

Dr Jennifer Guy MD MAS is a transplant hepatologist and Director of the Liver Cancer Program at California Pacific Medical Center. She is the Kranzusch Bosworth Endowed Chair for Innovation in Transplant Medicine with a focus on optimizing the patient experience.

Rotonya McCants Carr, MD is the Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington. She is a basic science researcher and clinical hepatologist who specializes in the care of patients with fatty liver diseases. Her laboratory uses complementary in vivo and cellular approaches to investigate the mechanisms of insulin resistance in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and alcohol-associated liver disease (ALD). Dr.

Teresa (Terry) Wright is currently Vice President and Clinical Research Head for Hepatology at GSK with responsibility for oversight of clinical development of investigational agents for patients with viral, metabolic and autoimmune liver diseases.